跳至主要内容
临床试验/NL-OMON38887
NL-OMON38887已完成4 期

The effect of maltitol sweetened chewing gum on the oral microbiology. - Effect of maltitol sweetened chewing gum on the oral microbiology.

ACTA Dental Research B.V. (ADR)0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Male and female - Age *18 years - Classified as systemically healthy, assessed by medical questionnaire - Non-smokers - Minimum of 20 natural teeth: at least 5 evaluable teeth in each quadrant - DPSI 0-3- - With moderate gingivitis (30-60% BOMP) - No partial dentures - No orthodontic banding - No oral lesions - Subjects who do not use a interdental device at home. - No use of antibiotics 60 days before baseline - No pregnancy/breast feeding - No participation in clinical trials 30 days before baseline - No consumer of > 3 sugar free chewing gums a day - Willing and able to give written informed consent - No medication except for birth control pills

排除标准

  • - Anyone presenting with a probing depth * 5mm with bleeding on probing and attachment loss * 2 mm - Overt dental caries - Usage of any interdental device as part of regular daily oral care - Smokers - DPSI 3+-4 - Removable (partial) dentures - Crowns, bridges and implant supported restorations - Removable night guard - Oral and/or peri-oral piercings - Apparent oral lesions (aphthous ulcers excluded) - Presence of orthodontic banding (except for lingual retention wire) - Dental student or dental professional - Participation in a clinical study within the previous 30 days ;General health and use of medication:
  • - Self-reported pregnancy or breastfeeding - Use of antibiotics during the last 2 months - Need of antibiotic prophylaxis prior to dental treatment - Use of anti-inflammatory drugs on a regular basis - Evidence of any systemic disease or compromised health condition - Adverse medical history or long-term medication - Prescribed medication (except for birthcontrol pills)

研究者

发起方
ACTA Dental Research B.V. (ADR)

相似试验